MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

08 Nov 2023 Evaluate
The quarter ended September 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1666.44 millions.Net Profit witnessed a 1428.81% growth almost the double from Rs. 7.88 millions to Rs. 120.47  millions  of same quarter last year.Operating Profit saw a handsome growth to 286.32 millions from 142.31 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1666.44 1594.33 4.52 3019.83 2238.22 34.92 5220.51 5198.74 0.42
Other Income 8.10 6.14 31.92 13.23 14.15 -6.50 48.86 51.98 -6.00
PBIDT 286.32 142.31 101.19 558.03 146.08 282.00 595.90 1196.83 -50.21
Interest 55.72 52.43 6.28 118.95 100.93 17.85 219.15 188.75 16.11
PBDT 230.60 89.88 156.56 439.08 45.15 872.49 376.75 1008.08 -62.63
Depreciation 79.00 80.92 -2.37 155.91 160.26 -2.71 321.25 321.52 -0.08
PBT 151.60 8.96 1591.96 283.17 -115.11 -346.00 55.50 686.56 -91.92
TAX 31.13 1.08 2782.41 69.87 -24.94 -380.15 14.65 6.18 137.06
Deferred Tax 0.13 1.08 -87.96 4.87 -24.94 -119.53 14.69 -143.02 -110.27
PAT 120.47 7.88 1428.81 213.30 -90.17 -336.55 40.85 680.38 -94.00
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 17.18 8.93 92.49 18.48 6.53 183.13 11.41 23.02 -50.42
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..